Castimycin has been shown to inhibit the activity of DNMT1, leading to the demethylation and increased expression of miR-148a-3p, which in turn suppresses the stemness traits of HCC cells [60]. This evidence concerns the gene DNMT1 and hepatocellular carcinoma.